ClinicalTrials.gg
Enrolling by invitationNCT06476106Updated Apr 1, 2025

Human Research Program Flight Thigh Cuff

An interventional study of Venoconstrictive Thigh Cuff (VTC) in Healthy, sponsored by National Aeronautics and Space Administration (NASA). Enrolling by invitation at 1 site in United States. Per ClinicalTrials.gov, last updated 2025-04-01.

Sponsored by National Aeronautics and Space Administration (NASA) · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Mar 2023, registered Mar 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Sex
All
01

Study summary

Venoconstrictive Thigh Cuffs (VTC) are being evaluated to determine the effectiveness at reversing the headward fluid shift that occurs during weightlessness. If successful, future studies may be done to implement these as a CM to SANS. To support this effort, participants will participate in 2 preflight study sessions consisting of a VTC fit check and a baseline data collection without and with the VTC donned. Participants will also participate in 3 inflight study sessions: a VTC fit check on flight day 30 (FD30) and two separate data collection sessions on flight day 45 (FD45) and 45 days before landing (R-45). During the two in-flight data collection days, participants will be studied before and for up to 6 hours after donning the VTC.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

National Aeronautics and Space Administration (NASA) is the lead sponsor of 14 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Astronauts participating in missions that are ≥2 months

Exclusion criteria

Exclusion Criteria:

  • Having known allergies to proparacaine hydrochloride ophthalmic solution precludes participation in this study
  • Use of ethinyl estradiol Combined Oral (COC) pills precludes participation in this study
  • Having increased risk of venothromboembolism (VTE) based on preflight thrombosis/clotting related biomarkers precludes participation in this study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Flight Thigh Cuff Crew Participants

    Participants will participate in 2 preflight study sessions consisting of a VTC fit check and a baseline data collection without and with the VTC donned. Participants will also participate in 3 inflight study sessions: a VTC fit check on flight day 30 (FD30) and two separate data collection sessions on flight day 45 (FD45) and 45 days before landing (R-45). During the two in-flight data collection days, participants will be studied before and for up to 6 hours after donning the VTC.

    Device: Venoconstrictive Thigh Cuff (VTC)

Interventions

  • DeviceVenoconstrictive Thigh Cuff (VTC)

    The VTC is an adjustable fabric cuff that is worn on the upper thighs to retain some fluid in the legs. It consists of wide straps and a buckle which allow it to be tightened, then velcro to secure the strap in the tightened position. There is also lacing that can be tightened for micro adjustments. Imbedded within the fabric strap is a bladder that is not used for increasing tightness but allows the pressure of the cuff to be measured and tracked.

    Also known as: Thigh Cuff

06

What researchers measure

Primary outcomes

  1. Internal Jugular Vein (IJV) area

    Measured using Ultrasound.

    Time frame: Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before return

  2. IJV pressure

    Measured using the VeinPres device during Ultrasound.

    Time frame: Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before return

  3. Intraocular Pressure (IOP)

    Measured using the Pneumatonometer.

    Time frame: Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before return

  4. stroke volume

    Measured from data collected during Ultrasound.

    Time frame: Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before return

07

Study locations

1 site
  • Johnson Space Center, National Aeronautics and Space Administration
    Houston, Texas 77058, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2023 (actual). Primary completion is estimated for May 2028, 61 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2024
First posted
Jun 26, 2024
StartActual
Mar 24, 2023
Primary completionEst.
May 14, 2028
CompletionEst.
May 14, 2030
Last update
Apr 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06476106
Lead sponsor
National Aeronautics and Space Administration (NASA)
Responsible party
Sponsor
First posted
Jun 26, 2024
Start date
Mar 24, 2023
Primary completion
May 14, 2028 (estimated)
Completion
May 14, 2030 (estimated)
Last update
Apr 1, 2025

Study contacts

Brandon R Macias, PhD
principal investigator · National Aeronautics and Space Administration (NASA)

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion